Suven Life Sciences Limited, a Hyderabad-based biopharmaceutical company specialising in central nervous system (CNS) diseases, has received patents for two new chemical entities (NCEs) from the US Patent office.

The two NCEs are indicated for the treatment of disorders associated with neurodegenerative diseases and these patents are valid until 2022 and 2024 respectively.

BSE  |  NSE Price

Click here for Cloud Computing

Also Read   Related Stories News Now - SC issues notices to Centre, others on Novartis petition - Road to recovery: Gujarat's pharma share rises to 30% - Suven Life's drug discovery achieves milestone - Aurobindo Pharma receives Swissmedic approval - Ranbaxy to launch Rocaltrol(R) in US soon - Cipla to raise Rs 1,500 cr by issue of shares

Also Read   Related Stories News Now - Wall Street opens flat as data offsets Moody's warning - Thomas Cook India Q4 net jumps three times - Govt plans to make 30% sourcing from MSEs mandatory - Explain ways to cover govt loss on 3G roaming: TDSAT to telcos - Magma Fincorp plans to start gold finance biz in H1 of FY13 More

In a filing to the BSE on Monday, Suven Life said the granted claims of the patents included the class of selective 5-HT compounds discovered by the company and were being developed as therapeutic agents and are used in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, attention deficient hyperactivity disorder, Huntington's disease, Parkinson and Schizophrenia.

The scrip of Suven Life is currently trading at Rs 31.55 on the BSE, up 4.99 per cent as against the previous close of Rs 30.05.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Wall Street opens flat as data offsets Moody's warning - Thomas Cook India Q4 net jumps three times - Govt plans to make 30% sourcing from MSEs mandatory - Explain ways to cover govt loss on 3G roaming: TDSAT to telcos - Magma Fincorp plans to start gold finance biz in H1 of FY13

Tags : Suven Life Sciences | pharma industry | ANDA | IPR | patent | us fda | parkinson's disease |   Read Business news in  Advertisements -  Now property search gets more exciting than ever before! -  High Growth Business Opportunities in Africa - Register to explore -  Medium-sized businesses are the engines of a smarter planet. -  Save over Rs.3000 with IndianOil Citibank Card -  We live for our family. have you secured them? -  India's No. 1 Property Site. Click here to know more.. -  Diseases earlier, Saving Costs, Extending Lives. Know More.. -  Get 5% cashback on telephone bills with Citi -  Enjoy the journey as much as the destination. click to know more.. -  Exim Bank Conclave on India - Africa Project Partnership. Know more.. -  Be part of it The World's Largest Aircraft. -  Creating Wealth made simple the SIP way. Know more.. -  Only Developer to give a guarantee on time space & rate. -  Office 365 for professionals and small businesses. -  Buy Your Property with Our Triple Guarantee in India. -  Improve Patient Care & Experience. Click here to know more -  Win a Business Class Ticket to Europe..Know more.. -   Introduce a New Automotive Luxury Car.. know more -  Health is Wealth..... Insurance + Savings... Know More...